Studies using dynasore, an endocytosis inhibitor, demonstrate that blocking receptor internalization prevents BPC-157's angiogenic effects, confirming the importance of this pathway
purelyIV education NAD+ therapy B12 support By Erin Boumansour At purelyIV, we make wellness support more accessible by bringing IV visits to your home, office, or hotel
Research literature characterised honestly qualified throughout ("research models," "in vitro/in vivo/clinical" distinction made explicit), no overstatement
as for patients with neurological improvement, 1 mg IM OH-Cbl on alternate days until there is no clinical improvement and then maintenance 1 mg IM OH-Cbl every 2 months is recommended ( g low-dose daily oral CN-Cbl is licensed ( In Canada, advice from the British Columbia Medical Association outlines that 1 mg daily oral CN-Cbl should be used for pernicious anemia or food-bound cobalamin malabsorption (FBCM) whereas in most other cases, a daily dose of 250 g may be used ( In Netherlands, controversy arose when the Dutch Organization of General Practitioners published a 2014 viewpoint that 1 mg daily oral OH-Cbl can be utilised as treatment in cases with a cobalamin count below 148 pmol/L and clinical symptoms, with the Dutch B12 Society disputing the efficacy of this and insisting that the advice from the Dutch Healthcare Institute Pharmacotherapeutic Compass should be followed instead (IM/SC starting dose of 10 injections of 1 mg OH-Cbl at intervals of at least 3 days
Having competed at the highest level, he understands what it takes to get you back to what you love with a focus on regenerative, minimally invasive care
